Fast, Guided Testing
Perform a complete self-assessment in under 5 minutes—anytime, anywhere. No lab. No clinician required.
The Eforto® System enables the monitoring of grip strength, muscle fatigability, and self-perceived fatigue—key biomarkers for assessing Vitality Capacity through a simple, guided 5-minute effort test.
Whether you're a healthcare provider, researcher, health coach, or an older adult, Eforto delivers instant, objective insights in prevention, triage, rehabilitation, disease management and clinical research.
These insights capture essential aspects of your neuromuscular health and energy metabolism—key indicators of your body's resilience, early signs of frailty, and potential low-grade inflammation.
ergonomic handgrip device for measuring strength and endurance
guides validated self-tests and visualizes results
secure remote monitoring and analytics dashboard
Outperforms traditional dynamometers
The ergonomic bulb is superior compared to classic isometric dynamometers.
With only 100g, Eforto is usable by even the weakest persons.
Medical grade pressure sensor with auto-calibration before each test.
The Eforto® M1 Vigorimeter is registered at FDA for medical use in the USA.
Guided self testing with validated protocols
Validated protocol to assessing Vitality Capacity biomarkers in less than 5 minutes.
It takes less than 5 minutes to perform the validated test protocol and get your results.
Interactive guidance by the app allows self-testing for monitoring at home.
Remote Monitoring with insightful metrics
Remote Monitoring with tracking the evolution of Eforto® biomarkers over time.
Algorithms analyse test data automatically, providing results with traffic light coding.
Compliant data processing with security and interoperability (API) by design. HIPAA, GDPR and ISO27001.
Perform a complete self-assessment in under 5 minutes—anytime, anywhere. No lab. No clinician required.
Receive a traffic-light score based on validated reference values. Red = Risk, Green = Resilient. Simple, actionable feedback.
Captures biomarkers recognized by the World Health Organization and validated in over 20 scientific publications.
Identify early signs of physical decline before symptoms appear, allowing for timely lifestyle or clinical interventions. CPV reliably detects subclinical frailty early, with each unit in increase linked to a 78% lower odds of pre-frailty in women.
Muscle fatigability predicts functional decline, hospitalization risk and mobility loss more effectively than standard assessments alone.
Muscle fatigability faster detects measurable improvements post-intervention, such as 63% improvement in grip fatigue resistance after anti-inflammatory treatment.
Used by:
When it comes to grip strength testing, not all measurements are created equal. Besides key biomarkers like Fatigability and CPV that traditional dynamometers miss, their measurements are affected by important variables that introduce multiple hidden bias, as supported by multiple peer-reviewed studies
Larger hands can register higher grip force on a dynamometer, even if actual muscle strength isn’t greater. Multiple clinical studies found readings from a dynamometer correlated with palm width, hand length, and forearm size.
The rigid grips and fixed spacing of many dynamometers can be uncomfortable for people with arthritis, smaller hands, or weaker strength, leading to underestimation. Research shows this design can compromise both comfort and accuracy.
Even when reliable, different dynamometers in test-to-test situations, they often produce different results, indicating a lack of validity, complicating comparisons in clinical or research settings.
When it comes to grip strength testing, not all measurements are created equal. Sugiyama, T., Whitney, D.G., Schmidt, M., Haapala, H., Bowman, A., Peterson, M.D. and Hurvitz, E.A., 2024. Measuring grip strength in adolescents and adults with cerebral palsy in a clinic setting: Feasibility, reliability, and clinical associations. Developmental Medicine & Child Neurology, 66(1), pp.87-94.
Besides key biomarkers like Fatigability and CPV that traditional dynamometers miss to measure, their measurements are affected by important variables that introduce hidden bias, as supported by multiple peer-reviewed studies
Larger hands can register higher grip force on a dynamometer, even if actual muscle strength isn’t greater. A 339-participant trial found readings from a dynamometer correlated with palm width, hand length, and forearm size (Neumann, S., Kwisda, S., Krettek, C. and Gaulke, R., 2017. Comparison of the grip strength using the Martin-Vigorimeter and the JAMAR-dynamometer: establishment of normal values. in vivo, 31(5), pp.917-924.)
The rigid grips and fixed spacing of many dynamometers can be uncomfortable for people with arthritis, smaller hands, or weaker strength, leading to underestimation. Research shows this design can compromise both comfort and accuracy.
(Gränicher, P., Maurer, Y., Spörri, J., Haller, B., Swanenburg, J., de Bie, R.A., Lenssen, T.A. and Scherr, J., 2024. Accuracy and Reliability of Grip Strength Measurements: A Comparative Device Analysis. Journal of Functional Morphology and Kinesiology, 9(4), p.274.)
Even when reliable, different dynamometers often produce slightly different results, indicating a lack of validity. complicating comparisons in clinical or research settings. (Benton, M.J., Spicher, J.M. and Silva-Smith, A.L., 2022. Validity and reliability of handgrip dynamometry in older adults: A comparison of two widely used dynamometers. PLoS One, 17(6), p.e0270132.
Eforto® is a vigorimeter measurement device designed to calculate a comprehensive muscle assessment for frailty prediction to track recovery status relative to hand surface area.
This means:
By measuring force per unit area, Eforto® eliminates the hidden biases of traditional devices giving clinicians, researchers, and patients a more equitable, replicable and anatomically fair assessment of the true strength test.
Eforto® is a Vigorimeter measurement device used to calculate a comprehensive muscle profile assessment relative to hand surface area.
This means:
By measuring force per unit area, Eforto® eliminates the hidden biases of traditional devices, giving clinicians, researchers, and patients a more equitable and anatomically fair assessment of the true strength test. De Dobbeleer, L., Beckwée, D., Arnold, P., Baudry, S., Beyer, I., Demarteau, J., Lieten, S., Punie, Y. and Bautmans, I., 2023. Comparison between two different handgrip systems and protocols on force reduction in handgrip assessment. Gerontology, 69(10), pp.1245-1254.
Eforto® : Towards a comprehensive profile of muscle power, endurance, and perceived vitality
While dynamometers only capture one-time grip strength, Eforto®’s power also captures how long strength is sustained, revealing muscular endurance and fatigue, not just maximal output.
Among octogenarians who didn’t report fatigue, those with lower Grip Work and CPV scores and higher self-perceived fatigue were more likely to be pre-frail, even though traditional strength tests appeared normal.
Eforto®’s multi-step grip strength test goes beyond a single snapshot, delivering a complete vitality profile that predicts fraility, measures strength, endurance, and recovery, helping detect changes that traditional tests often miss.